Literature DB >> 35258413

Hsa-miR-186-3p suppresses colon cancer progression by inhibiting KRT18/MAPK signaling pathway.

Tian Xia1, Zhiyong Zhang2, Xin Zhang2, Quanfu Li3.   

Abstract

This study aimed to determine the effect of miR-186-3p and KRT18 interaction on the biological behavior of colon cancer cells. A biotin-microRNA pull-down assay was performed to identify potential miRNAs. qRT-PCR was used to verify the KRT18 and miR-186-3p levels. In addition, Western blotting was used to detect the KRT18 protein levels. The functional connection between KRT18 and miR-186-3p was confirmed using a dual luciferase reporter assay. BrdU incorporation, MTT assay, and flow cytometry were performed to verify the biological function coupled with in vivo assays. A significant decrease in miR-186-3p expression was observed in colon carcinoma tissues and cells. Functionally, overexpression of miR-186-3p displayed an obvious suppressive action on cell proliferation and viability, and a stimulatory action on the apoptotic ability of SW620 and SW480 cells. Conversely, reduced miR-186-3p had a marked stimulatory effect on proliferation and viability, and a suppressive apoptotic effect. Inhibition of tumorigenesis was observed in mice treated with the miR-186-3p agomir. Furthermore, we identified that miR-186-3p regulated KRT18 levels in colon carcinoma, where silenced KRT18 suppressed proliferation and viability and promoted apoptosis. However, the addition of a miR-186-3p inhibitor weakened the effects of si-KRT18. Additionally, the activation of MAPK signaling pathway upon miR-186-3p silencing was antagonized by the combined transfection of si-KRT18 and miR-186-3p inhibitor. miR-186-3p suppresses proliferation and viability, but facilitates apoptosis in colon cancer cells by targeting KRT18 and negatively regulating the MAPK signaling pathway, indicating that the miR-186-3p/KRT18 axis may be a promising therapeutic target for colon carcinoma.Abbreviations: KRT18: keratin 18; NC: negative control; si‑: small interfering RNA; inhibitor: miR-186-3p inhibitor; OD: optical density; PI: propidium iodide; FITC: fluorescein isothiocyanate; 3'UTR: 3'untranslated region; WT: wild-type; MUT: mutant-type; miR: microRNA.

Entities:  

Keywords:  KRT18; apoptosis; colon cancer; miR-186-3p; proliferation; viability

Mesh:

Substances:

Year:  2022        PMID: 35258413      PMCID: PMC8973355          DOI: 10.1080/15384101.2021.2023305

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   5.173


  30 in total

Review 1.  Keratin expression in human tissues and neoplasms.

Authors:  P G Chu; L M Weiss
Journal:  Histopathology       Date:  2002-05       Impact factor: 5.087

2.  The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells.

Authors:  Mengjia He; Qianni Jin; Cong Chen; Yifeng Liu; Xiangsen Ye; Yulin Jiang; Feihu Ji; Husun Qian; Delu Gan; Shujun Yue; Wei Zhu; Tingmei Chen
Journal:  Oncogene       Date:  2019-04-09       Impact factor: 9.867

Review 3.  miRNAs, cancer, and stem cell division.

Authors:  Carlo M Croce; George A Calin
Journal:  Cell       Date:  2005-07-15       Impact factor: 41.582

Review 4.  Epigenetics in cancer: Fundamentals and Beyond.

Authors:  Subhankar Biswas; C Mallikarjuna Rao
Journal:  Pharmacol Ther       Date:  2017-02-08       Impact factor: 12.310

5.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

Review 6.  Epigenetics of colon cancer.

Authors:  Sharad Khare; Mukesh Verma
Journal:  Methods Mol Biol       Date:  2012

7.  [Expression of hsa-miR-186 and its role in human colon carcinoma cells].

Authors:  Fang Chen; Chang Zhou; Yanxia Lu; Li Yuan; Fanli Peng; Lin Zheng; Xuenong Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2013-05

8.  Multi-level evidence that circulating CK18 is a biomarker of tumour burden in colorectal cancer.

Authors:  A Greystoke; E Dean; M P Saunders; J Cummings; A Hughes; M Ranson; C Dive; A G Renehan
Journal:  Br J Cancer       Date:  2012-09-20       Impact factor: 7.640

9.  Predictive gene signatures: molecular markers distinguishing colon adenomatous polyp and carcinoma.

Authors:  Janice E Drew; Andrew J Farquharson; Claus Dieter Mayer; Hollie F Vase; Philip J Coates; Robert J Steele; Francis A Carey
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

10.  Cytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumour response.

Authors:  L C Scott; T R J Evans; J Cassidy; S Harden; J Paul; R Ullah; V O'Brien; R Brown
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.